Insmed Inc. appointed Leo Lee as a board member.
Lee most recently served as the president of Japan at Merck KGaA.
Bridgewater, N.J.-based Insmed is a biopharmaceutical company, which focuses on the development and commercialization of therapies for patients with rare diseases.
